United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $21.07 billion. The enterprise value is $16.73 billion.
| Market Cap | 21.07B |
| Enterprise Value | 16.73B |
Important Dates
The last earnings date was Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 43.06 million shares outstanding. The number of shares has decreased by -1.38% in one year.
| Current Share Class | 43.06M |
| Shares Outstanding | 43.06M |
| Shares Change (YoY) | -1.38% |
| Shares Change (QoQ) | -2.07% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 93.53% |
| Float | 40.05M |
Valuation Ratios
The trailing PE ratio is 18.55 and the forward PE ratio is 17.22. UTHR's PEG ratio is 4.45.
| PE Ratio | 18.55 |
| Forward PE | 17.22 |
| PS Ratio | 6.99 |
| Forward PS | 6.15 |
| PB Ratio | 3.19 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | 18.78 |
| P/OCF Ratio | 13.54 |
| PEG Ratio | 4.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.43, with an EV/FCF ratio of 14.91.
| EV / Earnings | 13.16 |
| EV / Sales | 5.35 |
| EV / EBITDA | 10.43 |
| EV / EBIT | 11.00 |
| EV / FCF | 14.91 |
Financial Position
The company has a current ratio of 6.40
| Current Ratio | 6.40 |
| Quick Ratio | 5.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 62.62 |
Financial Efficiency
Return on equity (ROE) is 20.04% and return on invested capital (ROIC) is 14.53%.
| Return on Equity (ROE) | 20.04% |
| Return on Assets (ROA) | 13.14% |
| Return on Invested Capital (ROIC) | 14.53% |
| Return on Capital Employed (ROCE) | 22.36% |
| Revenue Per Employee | $2.40M |
| Profits Per Employee | $974,483 |
| Employee Count | 1,305 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.21 |
Taxes
In the past 12 months, UTHR has paid $394.70 million in taxes.
| Income Tax | 394.70M |
| Effective Tax Rate | 23.69% |
Stock Price Statistics
The stock price has increased by +30.69% in the last 52 weeks. The beta is 0.86, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +30.69% |
| 50-Day Moving Average | 451.79 |
| 200-Day Moving Average | 349.77 |
| Relative Strength Index (RSI) | 67.76 |
| Average Volume (20 Days) | 424,335 |
Short Selling Information
The latest short interest is 1.65 million, so 3.83% of the outstanding shares have been sold short.
| Short Interest | 1.65M |
| Short Previous Month | 1.68M |
| Short % of Shares Out | 3.83% |
| Short % of Float | 4.12% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, UTHR had revenue of $3.13 billion and earned $1.27 billion in profits. Earnings per share was $26.38.
| Revenue | 3.13B |
| Gross Profit | 2.77B |
| Operating Income | 1.52B |
| Pretax Income | 1.67B |
| Net Income | 1.27B |
| EBITDA | 1.60B |
| EBIT | 1.52B |
| Earnings Per Share (EPS) | $26.38 |
Balance Sheet
The company has $2.77 billion in cash and n/a in debt, giving a net cash position of $4.33 billion or $100.68 per share.
| Cash & Cash Equivalents | 2.77B |
| Total Debt | n/a |
| Net Cash | 4.33B |
| Net Cash Per Share | $100.68 |
| Equity (Book Value) | 6.59B |
| Book Value Per Share | 153.61 |
| Working Capital | 2.95B |
Cash Flow
In the last 12 months, operating cash flow was $1.56 billion and capital expenditures -$434.30 million, giving a free cash flow of $1.12 billion.
| Operating Cash Flow | 1.56B |
| Capital Expenditures | -434.30M |
| Free Cash Flow | 1.12B |
| FCF Per Share | $26.06 |
Margins
Gross margin is 88.59%, with operating and profit margins of 48.64% and 40.65%.
| Gross Margin | 88.59% |
| Operating Margin | 48.64% |
| Pretax Margin | 53.27% |
| Profit Margin | 40.65% |
| EBITDA Margin | 51.28% |
| EBIT Margin | 48.64% |
| FCF Margin | 35.86% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.38% |
| Shareholder Yield | 1.38% |
| Earnings Yield | 6.04% |
| FCF Yield | 5.33% |
Analyst Forecast
The average price target for UTHR is $495.08, which is 1.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $495.08 |
| Price Target Difference | 1.18% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 11.55% |
| EPS Growth Forecast (5Y) | 10.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 15.06 and a Piotroski F-Score of 6.
| Altman Z-Score | 15.06 |
| Piotroski F-Score | 6 |